Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | glutamate receptor kainate | 0.003 | 0.1391 | 0.0365 |
Schistosoma mansoni | glutamate receptor NMDA | 0.003 | 0.1391 | 0.0365 |
Onchocerca volvulus | 0.0029 | 0.1197 | 0.5 | |
Onchocerca volvulus | 0.0029 | 0.1197 | 0.5 | |
Brugia malayi | Glutamate receptor 1 precursor | 0.003 | 0.1391 | 1 |
Onchocerca volvulus | 0.0029 | 0.1197 | 0.5 | |
Echinococcus granulosus | glutamate receptor ionotrophic AMPA 3 | 0.0035 | 0.6517 | 0.6044 |
Schistosoma mansoni | glutamate receptor kainate | 0.003 | 0.1391 | 0.0365 |
Onchocerca volvulus | 0.0029 | 0.1197 | 0.5 | |
Onchocerca volvulus | 0.0029 | 0.1197 | 0.5 | |
Onchocerca volvulus | 0.0029 | 0.1197 | 0.5 | |
Echinococcus multilocularis | Glutamate receptor, ionotropic kainate 3 | 0.0039 | 1 | 1 |
Onchocerca volvulus | 0.0029 | 0.1197 | 0.5 | |
Onchocerca volvulus | 0.0029 | 0.1197 | 0.5 | |
Schistosoma mansoni | ATP-binding cassette transporter | 0.003 | 0.1391 | 0.0365 |
Chlamydia trachomatis | glutamine binding protein | 0.0028 | 0 | 0.5 |
Schistosoma mansoni | glutamate receptor kainate | 0.003 | 0.1391 | 0.0365 |
Echinococcus multilocularis | Glutamate receptor, ionotropic kainate 2 | 0.0035 | 0.6517 | 0.6044 |
Onchocerca volvulus | 0.0029 | 0.1197 | 0.5 | |
Echinococcus granulosus | Glutamate receptor ionotropic kainate 2 | 0.0035 | 0.6517 | 0.6044 |
Onchocerca volvulus | 0.0029 | 0.1197 | 0.5 | |
Onchocerca volvulus | 0.0029 | 0.1197 | 0.5 | |
Onchocerca volvulus | 0.0029 | 0.1197 | 0.5 | |
Loa Loa (eye worm) | glutamate receptor 2 | 0.003 | 0.1391 | 1 |
Echinococcus granulosus | Glutamate receptor ionotropic kainate 2 | 0.0035 | 0.6517 | 0.6044 |
Mycobacterium ulcerans | glutamine-binding lipoprotein GlnH | 0.0028 | 0 | 0.5 |
Echinococcus multilocularis | glutamate receptor 2 | 0.003 | 0.1391 | 0.022 |
Echinococcus multilocularis | Glutamate receptor, ionotropic kainate 2 | 0.0035 | 0.6517 | 0.6044 |
Echinococcus granulosus | glutamate receptor 2 | 0.0035 | 0.6517 | 0.6044 |
Echinococcus granulosus | Glutamate receptor ionotropic kainate 2 | 0.0035 | 0.6517 | 0.6044 |
Schistosoma mansoni | glutamate receptor NMDA | 0.0035 | 0.6517 | 1 |
Echinococcus multilocularis | nmda type glutamate receptor | 0.0039 | 1 | 1 |
Treponema pallidum | amino acid ABC transporter, periplasmic binding protein | 0.0028 | 0 | 0.5 |
Onchocerca volvulus | Neuropeptide F receptor homolog | 0.0029 | 0.1197 | 0.5 |
Echinococcus multilocularis | glutamate receptor, ionotrophic, AMPA 3 | 0.0035 | 0.6517 | 0.6044 |
Onchocerca volvulus | 0.0029 | 0.1197 | 0.5 | |
Treponema pallidum | amino acid ABC transporter, periplasmic binding protein (hisJ) | 0.0028 | 0 | 0.5 |
Schistosoma mansoni | glutamate receptor AMPA | 0.003 | 0.1391 | 0.0365 |
Echinococcus granulosus | glutamate NMDA receptor subunit | 0.003 | 0.1391 | 0.022 |
Schistosoma mansoni | glutamate receptor AMPA | 0.003 | 0.1391 | 0.0365 |
Echinococcus multilocularis | glutamate receptor 2 | 0.0035 | 0.6517 | 0.6044 |
Onchocerca volvulus | Dopamine\/Ecdysteroid receptor homolog | 0.0029 | 0.1197 | 0.5 |
Chlamydia trachomatis | arginine ABC transporter substrate-binding protein ArtJ | 0.0028 | 0 | 0.5 |
Echinococcus multilocularis | glutamate (NMDA) receptor subunit | 0.003 | 0.1391 | 0.022 |
Loa Loa (eye worm) | glutamate receptor 1 | 0.003 | 0.1391 | 1 |
Echinococcus multilocularis | Glutamate receptor, ionotropic kainate 2 | 0.0035 | 0.6517 | 0.6044 |
Onchocerca volvulus | 0.0029 | 0.1197 | 0.5 | |
Onchocerca volvulus | 0.0029 | 0.1197 | 0.5 | |
Mycobacterium tuberculosis | Probable glutamine-binding lipoprotein GlnH (GLNBP) | 0.0028 | 0 | 0.5 |
Onchocerca volvulus | 0.0029 | 0.1197 | 0.5 | |
Onchocerca volvulus | 0.0029 | 0.1197 | 0.5 | |
Brugia malayi | Glutamate receptor 2 precursor | 0.003 | 0.1391 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | 0 mg kg-1 | Anticonvulsant activity of the compound against maximal electroshock induced seizures (MES) after 0.5 h at 300 mg/kg; Active | ChEMBL. | 2308142 |
Activity (functional) | 0 mg kg-1 | Anticonvulsant activity of the compound against maximal electroshock induced seizures (MES) after 4 hr at 300 mg/kg; Active | ChEMBL. | 2308142 |
Activity (functional) | 0 mg kg-1 | Anticonvulsant activity of the compound against subcutaneous administered Metrazol induced seizures (scMET) after 0.5 hr at 100 mg/kg; Active | ChEMBL. | 2308142 |
Activity (functional) | 0 mg kg-1 | Anticonvulsant activity of the compound against subcutaneous administered Metrazol induced seizures (scMET) after 4 hr at 300 mg/kg; Active | ChEMBL. | 2308142 |
ED50 (functional) | = 119.3 mg kg-1 | The effective dose of compound was tested against subcutaneous administered Metrazol induced seizures after intraperitoneal administration | ChEMBL. | 2308142 |
ED50 (functional) | = 119.3 mg kg-1 | The effective dose of compound was tested against subcutaneous administered Metrazol induced seizures after intraperitoneal administration | ChEMBL. | 2308142 |
ED50 (functional) | = 126.3 mg kg-1 | The effective dose of compound was tested against maximal electroshock induced seizures after intraperitoneal administration | ChEMBL. | 2308142 |
ED50 (functional) | = 126.3 mg kg-1 | The effective dose of compound was tested against maximal electroshock induced seizures after intraperitoneal administration | ChEMBL. | 2308142 |
Ratio (functional) | = 2.76 | Protective index was calculated (TD50/ED50) in MES assay in mice after intraperitoneal administration | ChEMBL. | 2308142 |
Ratio (functional) | = 2.92 | Protective index was calculated (TD50/ED50) in scMET assay in mice after intraperitoneal administration | ChEMBL. | 2308142 |
TD50 (ADMET) | = 348.6 mg kg-1 | The cytotoxicity of the compound after intraperitoneal administration | ChEMBL. | 2308142 |
TD50 (ADMET) | = 348.6 mg kg-1 | The cytotoxicity of the compound after intraperitoneal administration | ChEMBL. | 2308142 |
Toxicity (ADMET) | 0 mg kg-1 | The Neurologic toxicity of the compound was tested by measuring rotorod test after 0.5 h at 300 mg/kg; Active | ChEMBL. | 2308142 |
Toxicity (ADMET) | 0 mg kg-1 | The Neurologic toxicity of the compound was tested by measuring rotorod test after 4 hr at 300 mg/kg; Active | ChEMBL. | 2308142 |
TPE (ADMET) | = 1 | Time of peak effect was determined for toxicity | ChEMBL. | 2308142 |
TPE (functional) | = 2 | Time of peak effect was determined for activity in MES | ChEMBL. | 2308142 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.